Quick Answer
BeOne Medicines Ltd. reported Total Assets of $8.19 billion for fiscal year 2025.
BeOne Medicines Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $8.19B | +38.3% |
| 2024 | $5.92B | +2.0% |
| 2023 | $5.81B | -9.0% |
| 2022 | $6.38B | -25.3% |
| 2021 | $8.54B | +52.4% |
| 2020 | $5.60B | +247.4% |
| 2019 | $1.61B | -28.3% |
| 2018 | $2.25B | +115.0% |
| 2017 | $1.05B | +157.9% |
| 2016 | $405.81M | +247.5% |
| 2015 | $116.76M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.63B | +30.9% | +21.2% |
| June 30, 2025 | $6.30B | +10.3% | +7.8% |
| March 31, 2025 | $5.84B | +3.1% | -1.3% |
| December 31, 2024 | $5.92B | +2.0% | +1.5% |
| September 30, 2024 | $5.83B | +5.5% | +2.1% |
| June 30, 2024 | $5.71B | -0.3% | +0.8% |
| March 31, 2024 | $5.67B | -4.9% | -2.4% |
| December 31, 2023 | $5.81B | -9.0% | +5.1% |
- BeOne Medicines Ltd. showed an increase of +38.3% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, BeOne Medicines Ltd.’s total assets has grown by 6912.9% (from $116.76 million to $8.19 billion).
- The most recent figure is from BeOne Medicines Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: